What are the opening hours?

Monday 09:00 - 17:00 Tuesday 09:00 - 17:00 Wednesday 09:00 - 17:00 Thursday 09:00 - 17:00 Friday 09:00 - 17:00

Cuprina Wound Care Solutions

Home
Singapore
Singapore
Cuprina Wound Care Solutions

Developed in 2008, and re-launched in 2019, Cuprina Pte Ltd is a Singapore headquartered medical device manufacturing and distribution company.

We specialize in the manufacture of MEDIFLI, a biological debridement product.

23/02/2026

Proud to have supported the 2026 Symposium on Diabetic Wound Healing organised by The Hong Kong Society for Diabetic Limb Care, hosted at the on 7 February in Hong Kong.

This year’s symposium brought together clinicians, surgeons, podiatrists, and wound-care specialists for a full day of knowledge exchange across diabetic foot ulcer management, limb salvage strategies, advanced dressing techniques, NPWT — and importantly, Maggot Debridement Therapy (MDT).

At Cuprina, we were honoured to sponsor the MDT workshop by providing our medical-grade , enabling hands-on clinical learning around one of the most effective biological debridement methods available today. Seeing healthcare professionals engage directly with MDT in an academic clinical setting like HKU reinforces our belief that education, evidence, and real-world exposure are essential to advancing modern wound care.

A heartfelt thank you to the organisers, speakers, and participants for an inspiring day of collaboration and learning. We look forward to continuing our partnership with the wound-care community across Asia.

28/11/2025

🩺 Advanced wound care is transforming global healthcare—accelerating healing, reducing complications, and lowering treatment costs.

As outlined in “How Advanced Wound Care Innovations Are Transforming Global Healthcare”, the industry is evolving rapidly. From smart dressings that monitor healing in real time, to regenerative therapies and bioengineered skin substitutes, innovation is redefining how chronic wounds, burns, and surgical incisions are treated worldwide. With the global market expected to grow from USD 5.14 billion in 2024 to USD 7.47 billion by 2032, demand for patient-centric, effective wound care solutions is only accelerating.

At Cuprina (NASDAQ: CUPR), we are advancing this mission through innovative biomedical technologies—including our MEDIFLY® bio-dressing, collagen-based wound care solutions, and novel therapies that harness the natural healing power of biology. These advancements align with the global shift toward personalized medicine and value-based care, empowering healthcare providers to improve outcomes and transform patient lives.

🔗 Explore the article to learn how advanced wound care is shaping the future of healthcare: https://www.newstrail.com/advanced-wound-care/

16/10/2025

As global demand for advanced wound care continues to rise, driven by aging populations, chronic disease, and innovation in biologics, solutions that accelerate healing and reduce complications are more critical than ever.

At Cuprina, we’re proud to be part of this growing MedTech movement. Our clinically proven bio-dressing, MEDIFLY, harnesses the power of Maggot Debridement Therapy (MDT) to disinfect and debride chronic wounds such as diabetic foot and pressure ulcers. Used by leading hospitals in Singapore and Hong Kong, MEDIFLY helps eliminate infection, reduce amputation rates, and promote faster recovery in patients who need it most.

As the wound care market evolves with smart dressings, regenerative solutions, and increasing infrastructure investment, Cuprina remains committed to redefining chronic wound treatment with science-backed innovation.

🔗 Check out the article here: https://industrytoday.co.uk/health_and_safety/wound-care-market-size-2025-2033-biological-skin-substitutes-in-modern-wound-treatment

05/09/2025

Reimagining Wound Healing with Amphibian-Derived Innovation

Chronic wounds demand more than conventional care. At Cuprina, we’ve developed a biologically advanced solution to meet the challenge.

Introducing ANURAN SP1 — a next-generation collagen sponge dressing made from native Type I bullfrog collagen. Engineered to accelerate healing post-debridement, ANURAN SP1 provides a microporous scaffold that manages exudate, reduces inflammation, and supports granulation — guiding wounds toward closure.

With superior biocompatibility, tensile strength, and thermostability, ANURAN SP1 is more than a dressing — it’s a platform for regenerative recovery.

The future of wound care is amphibian-powered. https://cuprina.com/discover-anuran-collagen

08/08/2025

Healing the Future: Trends Reshaping Wound Care

As the wound care industry shifts toward advanced, personalized, and biologically driven solutions, Cuprina is proud to be at the forefront of this transformation.

This recent industry overview, “Healing the Future: Trends Driving the Wound Care Market”, highlights the rising demand for modern approaches to managing chronic wounds — a demand fueled by aging populations, diabetes prevalence, and the need for cost-effective, patient-centered care.

At Cuprina, we address this need through MEDIFLY®, our clinically proven maggot debridement therapy. By leveraging nature’s precision and science-backed efficacy, MEDIFLY is actively helping reduce amputation rates and eliminate infections in chronic wounds across hospitals in Singapore and Hong Kong.

From biologics to smart wound technologies, the future of wound care is one of innovation — and we’re proud to contribute to that future every day. Check out the article here: https://vocal.media/journal/healing-the-future-trends-driving-the-wound-care-market

24/07/2025

This week, Cuprina Wound Care Solutions ( CUPR) had the pleasure of hosting students from St. Paul’s Co-educational College, Hong Kong, at our lab in Singapore as part of their STEM school trip.

It was a meaningful opportunity to connect with the next generation of scientists and innovators, sharing insights into our biomedical research and development work. Their curiosity and enthusiasm made for an inspiring visit!

03/07/2025

Your skin trains with you. It deserves to recover with you.

Introducing MEND Skin Restoration Balm—Cuprina’s high-performance skincare formula designed for athletes, outdoor warriors, and everyday skin strugglers. Infused with collagen, hydroxyethyl urea, and natural plant extracts, MEND isn’t just hydration—it’s resilience in a jar.

From Singapore’s gyms to the trails of Australia, MEND is fueling skin recovery where the grind never stops. Whether you’re cycling in humidity or lifting in dry air, MEND restores the barrier, so your skin stays as strong as your goals.

📍Available now across Singapore, Malaysia, and Australia. Because peak performance starts at the surface. https://cuprina.com/mend-skin-restoration-balm

24/06/2025

The global healthcare landscape is increasingly recognizing the value of integrative and holistic approaches to patient care. In May 2025, the World Health Organization (WHO) launched its first-ever Traditional, Complementary, and Integrative Medicine (TCIM) dashboards, providing dynamic, real-time data to support evidence-based policymaking and strengthen global collaboration in this field.

Our MEDIFLY bio-dressing employs Maggot Debridement Therapy (MDT) to effectively disinfect and debride chronic wounds, while our upcoming bullfrog collagen dressings aim to support the body’s natural healing processes.

By integrating traditional wisdom with modern medical innovation, we strive to offer comprehensive care solutions that address the multifaceted needs of patients, particularly those with chronic wounds. Check out the article here: https://www.who.int/news/item/21-05-2025-who-unveils-groundbreaking-global-dashboards-for-traditional—complementary-and-integrative-medicine?

13/06/2025

The global diabetes epidemic continues to escalate, with projections indicating a 59.7% increase in prevalence between 2021 and 2050, rising from 6.1% to 9.8% of the global population. This surge underscores the urgent need for effective management strategies to mitigate associated complications, such as diabetic foot ulcers.

Cuprina Wound Care Solutions (Nasdaq: CUPR) is committed to addressing this challenge through innovative wound care solutions. Our MEDIFLY bio-dressing utilizes Maggot Debridement Therapy (MDT) to effectively disinfect and debride chronic wounds, reducing the risk of infections and amputations. Additionally, our research into collagen wound dressings derived from bullfrog skin has shown promising results in accelerating wound healing.

By focusing on advanced, nature-inspired therapies, we aim to improve outcomes for individuals affected by diabetes-related complications, contributing to global efforts in managing this growing health concern. Check out the article here: https://www.pharmacytimes.com/view/study-prevalence-of-diabetes-expected-to-increase-by-59-7-in-2025?

11/04/2025

We’re officially live on

Today marks a historic milestone: Cuprina is officially a publicly traded company under ticker Nasdaq: CUPR.

As a Singapore-based MedTech innovator, our mission has always been to bring science-backed, life-changing wound care to patients in need. Our flagship product MEDIFLY — a live, medical-grade maggot bio-dressing — is already transforming treatment outcomes for chronic wounds across Singapore and Hong Kong.

From hospital wards to the global markets, we’re just getting started.

Address

Singapore

Opening Hours

Monday	09:00 - 17:00
Tuesday	09:00 - 17:00
Wednesday	09:00 - 17:00
Thursday	09:00 - 17:00
Friday	09:00 - 17:00

Website

http://www.cuprina.com/

Alerts

Be the first to know and let us send you an email when Cuprina Wound Care Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cuprina Wound Care Solutions:

Want your business to be the top-listed Health & Beauty Business in Singapore?